Your session is about to expire
← Back to Search
Home Health Aide Support Tools for Heart Failure
N/A
Waitlist Available
Led By Madeline R Sterling, MD, MPH, MS
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Speak English or Spanish
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Summary
This trial will study whether an intervention can help home health aides better care for adults with heart failure, and improve the patient's overall health.
Who is the study for?
This trial is for home health aides with at least one year of experience, working at VNS Health Partners in Care, who speak English or Spanish and are caring for adults diagnosed with heart failure.
What is being tested?
The study tests whether a virtual training course and a mobile health (mHealth) app can boost the knowledge and confidence of home health aides in treating heart failure patients, potentially reducing emergency visits and hospital readmissions.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience increased workload or stress due to additional learning requirements.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can communicate in English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Heart Failure Caregiving Self-efficacy
Change in Heart Failure Knowledge
Secondary study objectives
Change in Intention to Leave
Change in Job Satisfaction
Other study objectives
Number of readmissions to the hospital
Number of visits to the emergency department
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention armExperimental Treatment2 Interventions
Home health aides in the intervention arm will receive a virtual heart failure training course and a communication-based messaging app.
Group II: Enhanced usual careActive Control1 Intervention
Home health aides in the enhanced usual care arm will receive a virtual heart failure training course.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
mHealth app
2021
N/A
~100
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,077 Previous Clinical Trials
1,320,562 Total Patients Enrolled
10 Trials studying Heart Failure
225,557 Patients Enrolled for Heart Failure
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,102 Total Patients Enrolled
208 Trials studying Heart Failure
677,604 Patients Enrolled for Heart Failure
Madeline R Sterling, MD, MPH, MSPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
1,254 Total Patients Enrolled
1 Trials studying Heart Failure
1,154 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have worked as a home health aide for at least a year.I can communicate in English or Spanish.I am caring for an adult at home who has been diagnosed with heart failure.
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced usual care
- Group 2: Intervention arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger